Prevalence of anti-histone antibodies, their clinical significance and correlation with other autoantibodies in a cohort of Italian scleroderma patients

Autoimmunity Highlights

Volumn 2, Issue 1, 2011, Pages 29-33

  Morozzi, Gabriella ^a   Bellisai, Francesca ^a   Fineschi, Irene ^a   Scaccia, Francesca ^a   Pucci, Gabriella ^a   Simpatico, Antonella ^a   Tampoia, Marilina ^b   Chialà, Alessandra ^b   Lapadula, Giovanni ^c   Galeazzi, Mauro ^a  

^a UNIVERSITY HOSPITAL OF SIENA   (Italy)

^b POLICLINICO   (Italy)

^c Sezione di Reumatologia   (Italy)

Author keywords

Anti histone antibodies; Clinical manifestations; Prevalence; Systemic sclerosis

Indexed keywords

AUTOANTIBODY; CENTROMERE PROTEIN B ANTIBODY; FIBRILLARIN ANTIBODY; HISTONE ANTIBODY; KU ANTIBODY; PM SCL ANTIBODY; RNA POLYMERASE III ANTIBODY; SCL 70 ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME IMMUNOASSAY; ETHNIC GROUP; FEMALE; FLUOROENZYME IMMUNOASSAY; HUMAN; HUMAN CELL; IMMUNOASSAY; IMMUNOFLUORESCENCE; ITALIAN; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS;

EID: 79955656054     PISSN: 20380305     EISSN: 20383274     Source Type: Journal    
DOI: 10.1007/s13317-011-0015-y     Document Type: Article

References (19)

1. Bunn CC, Denton CP, Shi-Wen X, Knight C, Black CM (1998) Anti-RNA polymerases and other autoantibody specificities in systemic sclerosis. Br J Rheumatol 37: 15-20.
2. Jacobsen S, Halberg P, Ullman S et al (1998) Clinical features and serum antinuclear antibodies in 230 Danish patients with systemic sclerosis. Br J Rheumatol 37: 39-45.
3. Tager RE, Tikly M (1999) Clinical and laboratory manifestations of systemic sclerosis (scleroderma) in black South Africans. Rheumatology 38: 397-400.
4. Kuwana M, Okano Y, Kaburaki J, Tojo T, Medsger TA Jr (1994) Racial differences in the distribution of systemic sclerosis-related serum antinuclear antibodies. Arthritis Rheum 37: 902-906.
5. Kuwana M, Kaburaki J, Arnett FC, Howard RF, Medsger TA Jr, Wright TM (1999) Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA-topoisomerase I antibody. Arthritis Rheum 42: 465-474.
6. Meyer OC, Fertig N, Lucas M, Somogyi N, Medsger TA Jr (2007) Disease subsets, antinuclear antibody profile, and clinical features in 127 French and 247 US adult patients with systemic sclerosis. J Rheumatol 34: 104-109.
7. Hesselstrand R, Scheja A, Shen GQ, Wiik A, Akesson A (2003) The association of antinuclear antibodies with organ involvement and survival in systemic sclerosis. Rheumatology (Oxford) 42: 534-540.
8. Chifflot H, Fautrel B, Sordet C, Chatelus E, Sibilia J (2008) Incidence and prevalence of systemic sclerosis: a systematic literature review. Semin Arthritis Rheum 37: 223-235.
9. Arias-Nuñez MC, Llorca J, Vazquez-Rodriguez TR et al (2008) Systemic sclerosis in northwestern Spain: a 19-year epidemiologic study. Medicine (Baltimore) 87: 272-280.
10. Walker UA, Tyndall A, Czirják L et al, EUSTAR co-authors (2009) Geographical variation of disease manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research (EUSTAR) group database. Ann Rheum Dis 68: 856-862.
11. Sato S, Ihn H, Kikuchi K, Kikuchi K, Takehara K (1994) Antihistone antibodies in systemic sclerosis: association with pulmonary fibrosis. Arthritis Rheum 37: 391-394.
12. Hasegawa M, Sato S, Kikuchi K et al (1998) Antigen specificity of antihistone antibodies in systemic sclerosis. Ann Rheum Dis 57: 470-475.
13. Parodi A, Drosera M, Barbieri L, Rebora A (1995) Antihistone antibodies in scleroderma. Dermatology 191: 16-18.
14. Parodi A, Drosera M, Barbieri L, Rebora A (2002) Scleroderma subsets are best detected by the simultaneous analysis of the autoantibody profile using commercial ELISA. Dermatology 204(1): 29-32.
15. Anonymous (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 23: 581-590.
16. LeRoy EC, Black C, Fleischmajer R et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15: 202-205.
17. Simonneau G, Robbins IM, Beghetti M et al (2009) Updated Clinical Classification of Pulmonary Hypertension. JACC 54 (1), Suppl S: S43-S54.
18. Steen VD (2005) Autoantibodies in systemic sclerosis. Semin Arthritis Rheum 35: 35-42.
19. Codullo V, Cavazzana I, Bonino C et al (2009) Serologic profile and mortality rates of scleroderma renal crisis in Italy. J Rheumatol 36: 1464-1469.